Universe Pharmaceuticals Appoints New Auditor
Ticker: UPC · Form: 6-K · Filed: Oct 10, 2024 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Oct 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, disclosure
Related Tickers: UPC
TL;DR
UPC swapped auditors on Oct 8th, bringing in Enrome LLP to replace YCM CPA INC.
AI Summary
Universe Pharmaceuticals INC (Nasdaq: UPC) announced on October 8, 2024, the appointment of Enrome LLP as its new independent registered public accounting firm. Enrome LLP replaces YCM CPA INC., the company's previous auditor.
Why It Matters
A change in auditor can signal potential shifts in financial reporting scrutiny or internal control assessments, which could impact investor confidence.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a change in auditor, which is a common corporate event and does not inherently present significant new risks.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Registrant
- Enrome LLP (company) — New independent registered public accounting firm
- YCM CPA INC. (company) — Former independent registered public accounting firm
- October 8, 2024 (date) — Date of auditor appointment
- Nasdaq: UPC (company) — Company ticker symbol
FAQ
Who is the new independent registered public accounting firm for Universe Pharmaceuticals INC?
Enrome LLP was appointed as the new independent registered public accounting firm for Universe Pharmaceuticals INC.
When was Enrome LLP appointed as the auditor?
Enrome LLP was appointed as the auditor on October 8, 2024.
Who did Enrome LLP replace as the auditor?
Enrome LLP replaced YCM CPA INC. as the independent registered public accounting firm.
What is the ticker symbol for Universe Pharmaceuticals INC?
The ticker symbol for Universe Pharmaceuticals INC is UPC.
What type of filing is this report?
This filing is a Form 6-K, Report of Foreign Private Issuer.
Filing Stats: 666 words · 3 min read · ~2 pages · Grade level 15.7 · Accepted 2024-10-10 16:10:23
Filing Documents
- ea0217201-6k_universe.htm (6-K) — 13KB
- ea021720101ex99-1_universe.htm (EX-99.1) — 2KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- 0001213900-24-086890.txt ( ) — 25KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Universe Pharmaceuticals INC. Date: October 10, 2024 By: /s/ Gang Lai Gang Lai Chief Executive Officer 2